DE60133319T3 - Mehrfach beschichete pharmazeutische dosierungsform - Google Patents

Mehrfach beschichete pharmazeutische dosierungsform Download PDF

Info

Publication number
DE60133319T3
DE60133319T3 DE60133319.5T DE60133319T DE60133319T3 DE 60133319 T3 DE60133319 T3 DE 60133319T3 DE 60133319 T DE60133319 T DE 60133319T DE 60133319 T3 DE60133319 T3 DE 60133319T3
Authority
DE
Germany
Prior art keywords
coating layer
poly
methacrylic acid
methyl methacrylate
dosage form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133319.5T
Other languages
German (de)
English (en)
Other versions
DE60133319D1 (de
DE60133319T2 (de
Inventor
Gregory DITTMAR
Joseph AMANTE
Tony Ryan Cronk
Daniel NEWBY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Co LLC
Original Assignee
Allergan Pharmaceuticals International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32823137&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60133319(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Pharmaceuticals International Ltd filed Critical Allergan Pharmaceuticals International Ltd
Publication of DE60133319D1 publication Critical patent/DE60133319D1/de
Publication of DE60133319T2 publication Critical patent/DE60133319T2/de
Application granted granted Critical
Publication of DE60133319T3 publication Critical patent/DE60133319T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60133319.5T 2001-11-23 2001-11-23 Mehrfach beschichete pharmazeutische dosierungsform Expired - Lifetime DE60133319T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01995903.0A EP1453487B2 (en) 2001-11-23 2001-11-23 Pharmaceutical dosage form with multiple coatings
PCT/US2001/043893 WO2003045356A1 (en) 2000-11-20 2001-11-23 Pharmaceutical dosage form with multiple coatings

Publications (3)

Publication Number Publication Date
DE60133319D1 DE60133319D1 (de) 2008-04-30
DE60133319T2 DE60133319T2 (de) 2009-04-30
DE60133319T3 true DE60133319T3 (de) 2021-08-05

Family

ID=32823137

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133319.5T Expired - Lifetime DE60133319T3 (de) 2001-11-23 2001-11-23 Mehrfach beschichete pharmazeutische dosierungsform

Country Status (15)

Country Link
EP (1) EP1453487B2 (enExample)
JP (1) JP4999037B2 (enExample)
CN (1) CN1314390C (enExample)
AT (1) ATE389389T1 (enExample)
AU (1) AU2002226955B2 (enExample)
BR (1) BRPI0117180B8 (enExample)
DE (1) DE60133319T3 (enExample)
DK (1) DK1453487T3 (enExample)
ES (1) ES2301575T5 (enExample)
HU (1) HU231030B1 (enExample)
IL (1) IL161628A (enExample)
MX (1) MXPA04004747A (enExample)
NZ (1) NZ532564A (enExample)
PT (1) PT1453487E (enExample)
WO (1) WO2003045356A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
CA2359812C (en) 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
PT2446881E (pt) * 2003-07-24 2014-06-11 Glaxosmithkline Llc Películas de dissolução oral
GB2407501A (en) * 2003-11-03 2005-05-04 Ist Superiore Sanita Nanoparticles for delivery of a pharmacologically active agent, comprising water insoluble (co)polymer core & hydrophilic acrylate-based (co)polymer shell
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
ES2323536T3 (es) * 2004-09-01 2009-07-20 The Procter And Gamble Company Composiciones que comprenden acido-5-amino-2-hidroxibenzoico yh un azucar reductor.
JP4938006B2 (ja) 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
WO2008093303A2 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
PL2152250T3 (pl) 2007-05-07 2020-06-15 Evonik Röhm Gmbh Stałe postaci dawkowania zawierające otoczkę dojelitową o przyspieszonym uwalnianiu leku
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB201202433D0 (en) 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
JP2012107058A (ja) * 2012-02-27 2012-06-07 Warner Chilcott Co Llc 複数のコーティングを有する医薬剤形
US20140141075A1 (en) * 2012-11-21 2014-05-22 Warner Chilcott Company, Llc 5-aminosalicylic acid capsule formulation
GB2510754B (en) * 2013-02-12 2016-07-13 Diurnal Ltd Controlled drug release
TWI688411B (zh) * 2013-02-22 2020-03-21 日商志瑞亞新藥工業股份有限公司 腸溶錠
JP6165022B2 (ja) * 2013-10-30 2017-07-19 株式会社ファンケル 放出制御型ソフトカプセル剤
WO2016001843A1 (en) * 2014-06-30 2016-01-07 Sun Pharmaceutical Industries Limited Extended-release gastroretentive tablets of voglibose
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN107661370A (zh) * 2017-11-20 2018-02-06 贵州浩诚药业有限公司 一种苦参片及其制备方法
JP2021528483A (ja) * 2018-05-03 2021-10-21 エムダブリュ エンキャップ リミテッド 下部胃腸管への医薬の送達のための剤形
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
CN113993509A (zh) * 2019-05-15 2022-01-28 赢创运营有限公司 用胶囊填充机制备具有基于(甲基)丙烯酸酯共聚物的包衣的填充硬壳胶囊的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
CN1239425A (zh) * 1996-11-15 1999-12-22 普罗克特和甘保尔公司 供结肠释放的具有多层肠溶聚合物包衣的药剂
AU5310898A (en) * 1996-12-20 1998-07-17 Dumex-Alpharma A/S Release-controlled coated tablets

Also Published As

Publication number Publication date
DK1453487T3 (da) 2008-07-21
ES2301575T5 (es) 2022-04-22
AU2002226955A1 (en) 2003-06-10
IL161628A0 (en) 2004-09-27
EP1453487B1 (en) 2008-03-19
MXPA04004747A (es) 2004-08-02
DE60133319D1 (de) 2008-04-30
NZ532564A (en) 2006-06-30
HUP0402230A2 (hu) 2005-02-28
BRPI0117180B1 (pt) 2018-12-04
WO2003045356A1 (en) 2003-06-05
BRPI0117180B8 (pt) 2021-05-25
EP1453487B2 (en) 2021-03-31
HUP0402230A3 (en) 2008-04-28
ATE389389T1 (de) 2008-04-15
BR0117180A (pt) 2004-11-03
AU2002226955B2 (en) 2006-04-27
DE60133319T2 (de) 2009-04-30
CN1314390C (zh) 2007-05-09
HU231030B1 (hu) 2019-12-30
CN1558754A (zh) 2004-12-29
JP4999037B2 (ja) 2012-08-15
ES2301575T3 (es) 2008-07-01
JP2005510539A (ja) 2005-04-21
PT1453487E (pt) 2008-05-13
IL161628A (en) 2014-03-31
EP1453487A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
DE60133319T2 (de) Mehrfach beschichete pharmazeutische dosierungsform
DE69717312T2 (de) Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden
EP0934058B1 (de) Stabile arzneiform mit benzimidazolderivaten als wirkstoff zur oralen verabreichung und verfahren zu ihrer herstellung
DE69719774T2 (de) Pharmazeutische dosierungsform mit mehrfachen enterischen polymer-überzügenzur abgabe im kolon
DE69109282T2 (de) Verfahren zum geschmacksabdecken von ibuprofen.
DE69832816T2 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69533470T2 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
DE69630286T2 (de) Aus mehreren einzeleinheiten zusammengesetzte dosierungsformen enthaltend einem protonen pumpen inhibitor
DE69624907T2 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
EP1024793B1 (de) Osmotisches arzneimittelfreisetzungssystem
EP0589981B1 (de) Pantoprazol enthaltende orale darreichungsformen
WO1995008323A1 (de) Budesonid-pellets mit kontrolliertem freigabeprofil und verfahren zu ihrer herstellung
DE19853487A1 (de) Verwendung von Dialkylfumaraten
DE69122751T2 (de) Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe
EP1748778A1 (de) Formulierungen mit kontrollierter wirkstoffreisetzung enthaltend vardenafil
WO1998023262A2 (de) Lutschtablette zur modifizierten freisetzung von wirkstoffen im gastrointestinaltrakt
DE10108122A1 (de) Arzneimittel auf Basis von Tramadol
WO2002017887A1 (de) Arzneimittel zur behandlung von darmerkrankungen
EP0994696A1 (de) Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
DE102009033621A1 (de) Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen
DE19850445A1 (de) Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
EP0324947B1 (de) Synergistische Kombination von Decarboxylasehemmern und L-Dopa-Pellets
DE2600021A1 (de) Pharmazeitisches praeparat zur behandlung von kreislaufstoerungen
EP0356699B1 (de) Fixe Arzneimittelkombination mit verzögerter Freisetzung
DE10108123A1 (de) Wirkstoffkombination

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: WARNER CHILCOTT COMPANY, LLC, FAJARDO, P.R., US